Showing results (2141-2150 of 6,800) with videos related to
Sort By:
Pageof 680
European Journal of Neurology|December 24, 2016
Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosisJ-W Hyun, G Park, K Kwak, et al.European Journal of Neurology|December 17, 2016
Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosisR Lanzillo, C Di Somma, M Quarantelli, et al.European Journal of Neurology|December 17, 2016
Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibilityA Martin-Bastida, N P Lao-Kaim, C Loane, et al.European Journal of Neurology|October 22, 2016
Effect of high-frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson's disease: a systematic review and meta-analysisC Schlenstedt, A Shalash, M Muthuraman, et al.European Journal of Neurology|October 27, 2016
Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorderH Chen, W Qiu, Q Zhang, et al.European Journal of Neurology|October 28, 2016
Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcomeC G Bien, Z Mirzadjanova, C Baumgartner, et al.European Journal of Neurology|October 5, 2016
Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosisJ Mellergård, A Tisell, I Blystad, et al.European Journal of Neurology|October 15, 2016
Exchangeable copper: a reflection of the neurological severity in Wilson's diseaseA Poujois, J-M Trocello, N Djebrani-Oussedik, et al.European Journal of Neurology|October 19, 2016
Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented stateH-J Kim, S-I Oh, M de Leon, et al.European Journal of Neurology|October 19, 2016
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?J Bonenfant, E Bajeux, V Deburghgraeve, et al.Pageof 680